Axxcess Wealth Management’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Buy |
29,840
+780
| +3% | +$53.8K | 0.05% | 289 |
|
|
2025
Q1 | $2.02M | Sell |
29,060
-688
| -2% | -$47.8K | 0.05% | 264 |
|
|
2024
Q4 | $2.56M | Buy |
29,748
+2,285
| +8% | +$197K | 0.06% | 230 |
|
|
2024
Q3 | $3.27M | Sell |
27,463
-252
| -0.9% | -$30K | 0.08% | 188 |
|
|
2024
Q2 | $3.96M | Buy |
27,715
+3,834
| +16% | +$547K | 0.1% | 157 |
|
|
2024
Q1 | $3.07M | Sell |
23,881
-7,128
| -23% | -$915K | 0.08% | 186 |
|
|
2023
Q4 | $3.21M | Buy |
31,009
+3,407
| +12% | +$352K | 0.09% | 177 |
|
|
2023
Q3 | $2.51M | Buy |
27,602
+4,380
| +19% | +$398K | 0.09% | 174 |
|
|
2023
Q2 | $1.88M | Buy |
23,222
+6,716
| +41% | +$543K | 0.14% | 141 |
|
|
2023
Q1 | $1.31M | Buy |
16,506
+1,444
| +10% | +$115K | 0.1% | 188 |
|
|
2022
Q4 | $1.02M | Buy |
15,062
+6,722
| +81% | +$455K | 0.08% | 220 |
|
|
2022
Q3 | $416K | Buy |
+8,340
| New | +$416K | 0.04% | 346 |
|
|
2022
Q1 | – | Sell |
-4,740
| Closed | -$265K | – | 681 |
|
|
2021
Q4 | $265K | Buy |
+4,740
| New | +$265K | 0.02% | 507 |
|